ReP USP - Resultado da busca

Artigo de periodico
Stemness signature stratifies gliomas with clinical importance and reveals a proliferative phenotype in single cell data (2022)
Simões, Renan ; Marção, Maycon ; Malta, Tathiane
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidades: FMRP, FCFRP
Subjects: GLIOMA, FENÓTIPOS, NEOPLASIAS DO SISTEMA NERVOSO, EXPRESSÃO GÊNICA, SEQUENCIAMENTO GENÉTICO, RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIMÕES, Renan e MARÇÃO, Maycon e MALTA, Tathiane. Stemness signature stratifies gliomas with clinical importance and reveals a proliferative phenotype in single cell data. Neuro-Oncology, v. 24, p. vii127, 2022Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noac209.482. Acesso em: 25 abr. 2026.
APA
Simões, R., Marção, M., & Malta, T. (2022). Stemness signature stratifies gliomas with clinical importance and reveals a proliferative phenotype in single cell data. Neuro-Oncology, 24, vii127. doi:10.1093/neuonc/noac209.482
NLM
Simões R, Marção M, Malta T. Stemness signature stratifies gliomas with clinical importance and reveals a proliferative phenotype in single cell data [Internet]. Neuro-Oncology. 2022 ; 24 vii127.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noac209.482
Vancouver
Simões R, Marção M, Malta T. Stemness signature stratifies gliomas with clinical importance and reveals a proliferative phenotype in single cell data [Internet]. Neuro-Oncology. 2022 ; 24 vii127.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noac209.482
Artigo de periodico
Loss of H3K27me3 in meningiomas (2021)
Nassir, Farshad; Wang, Justin Z.; Singh, Olivia; Karimi, Shirin; Dalcourt, Tatyana; Ijad, Nazanin; Pirouzmand, Neda; Ng, Ho-Keung; Saladino, Andrea; Noushmehr, Houtan
Source: Neuro-Oncology. Unidade: FMRP
Subjects: NEOPLASIAS MENÍNGEAS, MENINGIOMA, RECIDIVA LOCAL DE NEOPLASIA, REPRODUTIBILIDADE DE RESULTADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASSIR, Farshad et al. Loss of H3K27me3 in meningiomas. Neuro-Oncology, v. 23, n. 8, p. 1282-1291, 2021Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noab036. Acesso em: 25 abr. 2026.
APA
Nassir, F., Wang, J. Z., Singh, O., Karimi, S., Dalcourt, T., Ijad, N., et al. (2021). Loss of H3K27me3 in meningiomas. Neuro-Oncology, 23( 8), 1282-1291. doi:10.1093/neuonc/noab036
NLM
Nassir F, Wang JZ, Singh O, Karimi S, Dalcourt T, Ijad N, Pirouzmand N, Ng H-K, Saladino A, Noushmehr H. Loss of H3K27me3 in meningiomas [Internet]. Neuro-Oncology. 2021 ; 23( 8): 1282-1291.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noab036
Vancouver
Nassir F, Wang JZ, Singh O, Karimi S, Dalcourt T, Ijad N, Pirouzmand N, Ng H-K, Saladino A, Noushmehr H. Loss of H3K27me3 in meningiomas [Internet]. Neuro-Oncology. 2021 ; 23( 8): 1282-1291.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noab036
Trabalho de evento-resumo periodico
Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment (2021)
Varn, Frederick; Johnson, Kevin; Wade, Taylor; Malta, Tathiane; Sabedot, Thais; Barthel, Floris; Kim, Hoon; Ahmed, Nazia; Dalta, Indrani; Noushmehr, Houtan
Source: Neuro-Oncology. Conference titles: Annual Meeting & Education Day of the Society for Neuro-Oncology. Unidades: FMRP, FCFRP
Subjects: GLIOMA, PROGNÓSTICO, SEQUÊNCIA DO DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VARN, Frederick et al. Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noab196.008. Acesso em: 25 abr. 2026. , 2021
APA
Varn, F., Johnson, K., Wade, T., Malta, T., Sabedot, T., Barthel, F., et al. (2021). Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noab196.008
NLM
Varn F, Johnson K, Wade T, Malta T, Sabedot T, Barthel F, Kim H, Ahmed N, Dalta I, Noushmehr H. Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment [Internet]. Neuro-Oncology. 2021 ; 23 vi3.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noab196.008
Vancouver
Varn F, Johnson K, Wade T, Malta T, Sabedot T, Barthel F, Kim H, Ahmed N, Dalta I, Noushmehr H. Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment [Internet]. Neuro-Oncology. 2021 ; 23 vi3.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noab196.008
Trabalho de evento-resumo periodico
Apollo: Raman-based pathology of malignant glioma (2021)
Lita, Adrian; Sjöberg, Joel; Filipescu, Stefan; Celiku, Orieta; Petre, Luigia; Gilbert, Mark; Noushmehr, Houtan; Petre, Ion; Larion, Mioara
Source: Neuro-Oncology. Conference titles: Annual Meeting & Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: GLIOMA, METILAÇÃO DE DNA, ESPECTROSCOPIA RAMAN
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LITA, Adrian et al. Apollo: Raman-based pathology of malignant glioma. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noab196.497. Acesso em: 25 abr. 2026. , 2021
APA
Lita, A., Sjöberg, J., Filipescu, S., Celiku, O., Petre, L., Gilbert, M., et al. (2021). Apollo: Raman-based pathology of malignant glioma. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noab196.497
NLM
Lita A, Sjöberg J, Filipescu S, Celiku O, Petre L, Gilbert M, Noushmehr H, Petre I, Larion M. Apollo: Raman-based pathology of malignant glioma [Internet]. Neuro-Oncology. 2021 ; 23 vi125.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noab196.497
Vancouver
Lita A, Sjöberg J, Filipescu S, Celiku O, Petre L, Gilbert M, Noushmehr H, Petre I, Larion M. Apollo: Raman-based pathology of malignant glioma [Internet]. Neuro-Oncology. 2021 ; 23 vi125.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noab196.497
Artigo de periodico
DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features (2021)
Mosella, Maritza Queiroz Salas ; Sabedot, Thais Sarraf; Silva, Tiago Chedraoui ; Malta, Tathiane Maistro; Dezem, Felipe Segato; Asmaro, Karam P; Wells, Michael; Mukherjee, Abir; Poisson, Laila M; Snyder, James; Carvalho, Ana C. de; Walbert, Tobias; Aho, Todd; Kalkanis, Steven; Elias, Paula Conde Lamparelli ; Antonini, Sonir Roberto Rauber ; Rock, Jack; Noushmehr, Houtan ; Castro, Margaret de ; Castro, Ana Valéria
Source: Neuro-Oncology. Unidade: FMRP
Subjects: ESTUDOS DE COORTES, METILAÇÃO DE DNA, NEOPLASIAS HIPOFISÁRIAS, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOSELLA, Maritza Queiroz Salas et al. DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features. Neuro-Oncology, v. 23, n. 8, p. 1292-1303, 2021Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noab044. Acesso em: 25 abr. 2026.
APA
Mosella, M. Q. S., Sabedot, T. S., Silva, T. C., Malta, T. M., Dezem, F. S., Asmaro, K. P., et al. (2021). DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features. Neuro-Oncology, 23( 8), 1292-1303. doi:10.1093/neuonc/noab044
NLM
Mosella MQS, Sabedot TS, Silva TC, Malta TM, Dezem FS, Asmaro KP, Wells M, Mukherjee A, Poisson LM, Snyder J, Carvalho AC de, Walbert T, Aho T, Kalkanis S, Elias PCL, Antonini SRR, Rock J, Noushmehr H, Castro M de, Castro AV. DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features [Internet]. Neuro-Oncology. 2021 ; 23( 8): 1292-1303.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noab044
Vancouver
Mosella MQS, Sabedot TS, Silva TC, Malta TM, Dezem FS, Asmaro KP, Wells M, Mukherjee A, Poisson LM, Snyder J, Carvalho AC de, Walbert T, Aho T, Kalkanis S, Elias PCL, Antonini SRR, Rock J, Noushmehr H, Castro M de, Castro AV. DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features [Internet]. Neuro-Oncology. 2021 ; 23( 8): 1292-1303.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noab044
Trabalho de evento-resumo periodico
Epidemiological characteristics and survival of patients with diffuse glioma in Brazil: preliminary results of a multicentric retrospective study - LACOG 0619 (2021)
Yamada, Camilla; Vasques, Carolina; Coutinho, Rodrigo; Maldaun, Marcos Vinicius Calfat; Baldotto, Clarissa; Viola, Fabiana; Maluf, Fernando; Santos, Vanessa; Pessoa, Carolina; Pacheco, Patrícia; Matias, Danielli; Oliveira, Daniela; Peria, Fernanda Maris ; Jesus, Rafaela de; Rebelatto, Taiane; Malheiros, Suzana
Source: Neuro-Oncology. Conference titles: Annual Meeting and Education Day of the Society for Neuro-Oncology - SNO. Unidade: FMRP
Subjects: GLIOMA, SOBREVIVÊNCIA LIVRE DE DOENÇA, ESTUDOS RETROSPECTIVOS, EPIDEMIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YAMADA, Camilla et al. Epidemiological characteristics and survival of patients with diffuse glioma in Brazil: preliminary results of a multicentric retrospective study - LACOG 0619. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noab196.340. Acesso em: 25 abr. 2026. , 2021
APA
Yamada, C., Vasques, C., Coutinho, R., Maldaun, M. V. C., Baldotto, C., Viola, F., et al. (2021). Epidemiological characteristics and survival of patients with diffuse glioma in Brazil: preliminary results of a multicentric retrospective study - LACOG 0619. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noab196.340
NLM
Yamada C, Vasques C, Coutinho R, Maldaun MVC, Baldotto C, Viola F, Maluf F, Santos V, Pessoa C, Pacheco P, Matias D, Oliveira D, Peria FM, Jesus R de, Rebelatto T, Malheiros S. Epidemiological characteristics and survival of patients with diffuse glioma in Brazil: preliminary results of a multicentric retrospective study - LACOG 0619 [Internet]. Neuro-Oncology. 2021 ; 23 vi86-vi87.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noab196.340
Vancouver
Yamada C, Vasques C, Coutinho R, Maldaun MVC, Baldotto C, Viola F, Maluf F, Santos V, Pessoa C, Pacheco P, Matias D, Oliveira D, Peria FM, Jesus R de, Rebelatto T, Malheiros S. Epidemiological characteristics and survival of patients with diffuse glioma in Brazil: preliminary results of a multicentric retrospective study - LACOG 0619 [Internet]. Neuro-Oncology. 2021 ; 23 vi86-vi87.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noab196.340
Artigo de periodico
A serum-based DNA methylation assay provides accurate detection of glioma (2021)
Sabedot, Thais S; Malta, Tathiane M; Snyder, James; Nelson, Kevin; Wells, Michael; Carvalho, Ana C. de; Mukherjee, Abir; Chitale, Dhananjay A; Mosella, Maritza S; Sokolov, Artem; Asmaro, Karam P; Robin, Adam; Rosenblum, Mark L; Mikkelsen, Tom; Rock, Jack; Poisson, Laila M; Lee, Ian; Walbert, Tobias; Kalkanis, Steven; Iavarone, Antonio; Castro, Ana Valeria; Noushmehr, Houtan
Source: Neuro-Oncology. Unidade: FMRP
Subjects: BIOMARCADORES, GLIOMA, NEOPLASIAS CEREBRAIS, METILAÇÃO DE DNA, EPIGÊNESE GENÉTICA, BIÓPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABEDOT, Thais S et al. A serum-based DNA methylation assay provides accurate detection of glioma. Neuro-Oncology, v. 23, n. 9, p. 1494-1508, 2021Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noab023. Acesso em: 25 abr. 2026.
APA
Sabedot, T. S., Malta, T. M., Snyder, J., Nelson, K., Wells, M., Carvalho, A. C. de, et al. (2021). A serum-based DNA methylation assay provides accurate detection of glioma. Neuro-Oncology, 23( 9), 1494-1508. doi:10.1093/neuonc/noab023
NLM
Sabedot TS, Malta TM, Snyder J, Nelson K, Wells M, Carvalho AC de, Mukherjee A, Chitale DA, Mosella MS, Sokolov A, Asmaro KP, Robin A, Rosenblum ML, Mikkelsen T, Rock J, Poisson LM, Lee I, Walbert T, Kalkanis S, Iavarone A, Castro AV, Noushmehr H. A serum-based DNA methylation assay provides accurate detection of glioma [Internet]. Neuro-Oncology. 2021 ; 23( 9): 1494-1508.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noab023
Vancouver
Sabedot TS, Malta TM, Snyder J, Nelson K, Wells M, Carvalho AC de, Mukherjee A, Chitale DA, Mosella MS, Sokolov A, Asmaro KP, Robin A, Rosenblum ML, Mikkelsen T, Rock J, Poisson LM, Lee I, Walbert T, Kalkanis S, Iavarone A, Castro AV, Noushmehr H. A serum-based DNA methylation assay provides accurate detection of glioma [Internet]. Neuro-Oncology. 2021 ; 23( 9): 1494-1508.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noab023
Artigo de periodico
Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma (2021)
Tesileanu, C. Mircea S.; Van den Bent, Martin; Sanson, Marc; Wick, Wolfgang; Brandes, Alba; Clement, Paul M.; Erridge, Sara C.; Vogelbaum, Michael A.; Nowak, Anna; Baurain, Jean; Mason, Warren P.; Wheeler, Helen; Chinot, Olivier L.; Gill, Sanjeev; Griffin, Matthew; Rogers, Leland; Taal, Walter; Rudà, Roberta; Weller, Michael; McBain, Catherine; Linde, Myra E. van; Sabedot, Thais S.; Hoogstrate, Youri; Deimling, Andreas von; Heer, Iris de; IJcken, Wilfred F. J. van; Brouwer, Rutger W. W.; Aldape, Kenneth; Jenkins, Robert B.; Dubbink, Hendrikus; Kros, Johan M.; Wesseling, Pieter; Cheung, Kin Jip; Golfinopoulos, Vassilis; Baumert, Brigitta; Gorlia, Thierry; Noushmehr, Houtan; French, Pim
Source: Neuro-Oncology. Unidade: FMRP
Subjects: NEOPLASIAS CEREBRAIS, METILAÇÃO DE DNA, GLIOMA, MUTAÇÃO, ESTUDOS PROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TESILEANU, C. Mircea S. et al. Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma. Neuro-Oncology, v. 23, n. 9, p. 1547-1559, 2021Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noab088. Acesso em: 25 abr. 2026.
APA
Tesileanu, C. M. S., Van den Bent, M., Sanson, M., Wick, W., Brandes, A., Clement, P. M., et al. (2021). Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma. Neuro-Oncology, 23( 9), 1547-1559. doi:10.1093/neuonc/noab088
NLM
Tesileanu CMS, Van den Bent M, Sanson M, Wick W, Brandes A, Clement PM, Erridge SC, Vogelbaum MA, Nowak A, Baurain J, Mason WP, Wheeler H, Chinot OL, Gill S, Griffin M, Rogers L, Taal W, Rudà R, Weller M, McBain C, Linde ME van, Sabedot TS, Hoogstrate Y, Deimling A von, Heer I de, IJcken WFJ van, Brouwer RWW, Aldape K, Jenkins RB, Dubbink H, Kros JM, Wesseling P, Cheung KJ, Golfinopoulos V, Baumert B, Gorlia T, Noushmehr H, French P. Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma [Internet]. Neuro-Oncology. 2021 ; 23( 9): 1547-1559.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noab088
Vancouver
Tesileanu CMS, Van den Bent M, Sanson M, Wick W, Brandes A, Clement PM, Erridge SC, Vogelbaum MA, Nowak A, Baurain J, Mason WP, Wheeler H, Chinot OL, Gill S, Griffin M, Rogers L, Taal W, Rudà R, Weller M, McBain C, Linde ME van, Sabedot TS, Hoogstrate Y, Deimling A von, Heer I de, IJcken WFJ van, Brouwer RWW, Aldape K, Jenkins RB, Dubbink H, Kros JM, Wesseling P, Cheung KJ, Golfinopoulos V, Baumert B, Gorlia T, Noushmehr H, French P. Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma [Internet]. Neuro-Oncology. 2021 ; 23( 9): 1547-1559.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noab088
Artigo de periodico
Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas (2020)
Ruiz-Rodado, Victor; Malta, Tathiane Maistro; Seki, Tomohiro; Lita, Adrian; Dowdy, Tyrone; Celiku, Orieta; Cavazos-Saldana, Alejandra; Li, Aiguo; Liu, Yang; Han, Sue; Zhang, Wei; Song, Hua; Davis, Dionne; Lee, Sunmin; Trepel, Jane B.; Sabedot, Thais Sarraf; Munasinghe, Jeeva; Yang, Chunzhang; Herold-Mende, Christel; Gilbert, Mark R.; Cherukuri, Murali Krishna; Noushmehr, Houtan; Larion, Mioara
Source: Neuro-Oncology. Unidades: FCFRP, FMRP
Subjects: MUTAÇÃO GENÉTICA, GLIOMA, EPIGÊNESE GENÉTICA, METABOLISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUIZ-RODADO, Victor et al. Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas. Neuro-Oncology, v. 22, n. 4, p. 480-492, 2020Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noz207. Acesso em: 25 abr. 2026.
APA
Ruiz-Rodado, V., Malta, T. M., Seki, T., Lita, A., Dowdy, T., Celiku, O., et al. (2020). Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas. Neuro-Oncology, 22( 4), 480-492. doi:10.1093/neuonc/noz207
NLM
Ruiz-Rodado V, Malta TM, Seki T, Lita A, Dowdy T, Celiku O, Cavazos-Saldana A, Li A, Liu Y, Han S, Zhang W, Song H, Davis D, Lee S, Trepel JB, Sabedot TS, Munasinghe J, Yang C, Herold-Mende C, Gilbert MR, Cherukuri MK, Noushmehr H, Larion M. Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas [Internet]. Neuro-Oncology. 2020 ; 22( 4): 480-492.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noz207
Vancouver
Ruiz-Rodado V, Malta TM, Seki T, Lita A, Dowdy T, Celiku O, Cavazos-Saldana A, Li A, Liu Y, Han S, Zhang W, Song H, Davis D, Lee S, Trepel JB, Sabedot TS, Munasinghe J, Yang C, Herold-Mende C, Gilbert MR, Cherukuri MK, Noushmehr H, Larion M. Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas [Internet]. Neuro-Oncology. 2020 ; 22( 4): 480-492.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noz207
Trabalho de evento-resumo
Tumor-immune interactions are dynamic and influence the evolutionary trajectory of adult diffuse glioma (2020)
Varn, Frederick; Johnson, Kevin; Barthel, Floris; Kim, Hoon; Wade, Taylor; Lodha, Disha; Ajaib, Shoaib; Ahmed, Nazia; Garofano, Luciano; D’Angelo, Fulvio; Stead, Lucy; Noushmehr, Houtan ; Iavarone, Antonio; Verhaak, Roel
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: GLIOMA, NEOPLASIAS CEREBRAIS, SISTEMA IMUNE, SEQUENCIAMENTO GENÉTICO, RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VARN, Frederick et al. Tumor-immune interactions are dynamic and influence the evolutionary trajectory of adult diffuse glioma. 2020, Anais.. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2020. p. ii70. Disponível em: https://doi.org/10.1093/neuonc/noaa215.287. Acesso em: 25 abr. 2026.
APA
Varn, F., Johnson, K., Barthel, F., Kim, H., Wade, T., Lodha, D., et al. (2020). Tumor-immune interactions are dynamic and influence the evolutionary trajectory of adult diffuse glioma. In Neuro-Oncology (Vol. 22, p. ii70). Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noaa215.287
NLM
Varn F, Johnson K, Barthel F, Kim H, Wade T, Lodha D, Ajaib S, Ahmed N, Garofano L, D’Angelo F, Stead L, Noushmehr H, Iavarone A, Verhaak R. Tumor-immune interactions are dynamic and influence the evolutionary trajectory of adult diffuse glioma [Internet]. Neuro-Oncology. 2020 ; 22( suppl. 2): ii70.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noaa215.287
Vancouver
Varn F, Johnson K, Barthel F, Kim H, Wade T, Lodha D, Ajaib S, Ahmed N, Garofano L, D’Angelo F, Stead L, Noushmehr H, Iavarone A, Verhaak R. Tumor-immune interactions are dynamic and influence the evolutionary trajectory of adult diffuse glioma [Internet]. Neuro-Oncology. 2020 ; 22( suppl. 2): ii70.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noaa215.287
Trabalho de evento-resumo periodico
Epigenomics of the glioma longitudinal analysis (glass) consortium (2020)
Sabedot, Thais; Wells, Michael; Datta, Indrani; Malta, Tathiane; Castro, Ana Valeria; Poisson, Laila M; Verhaak, Roel; Iavarone, Antonio; Noushmehr, Houtan
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: GLIOMA, NEOPLASIAS CEREBRAIS, METILAÇÃO DE DNA, EPIGÊNESE GENÉTICA, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABEDOT, Thais et al. Epigenomics of the glioma longitudinal analysis (glass) consortium. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noaa215.308. Acesso em: 25 abr. 2026. , 2020
APA
Sabedot, T., Wells, M., Datta, I., Malta, T., Castro, A. V., Poisson, L. M., et al. (2020). Epigenomics of the glioma longitudinal analysis (glass) consortium. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noaa215.308
NLM
Sabedot T, Wells M, Datta I, Malta T, Castro AV, Poisson LM, Verhaak R, Iavarone A, Noushmehr H. Epigenomics of the glioma longitudinal analysis (glass) consortium [Internet]. Neuro-Oncology. 2020 ; 22( suppl. 2): ii75.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noaa215.308
Vancouver
Sabedot T, Wells M, Datta I, Malta T, Castro AV, Poisson LM, Verhaak R, Iavarone A, Noushmehr H. Epigenomics of the glioma longitudinal analysis (glass) consortium [Internet]. Neuro-Oncology. 2020 ; 22( suppl. 2): ii75.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noaa215.308
Trabalho de evento-resumo periodico
Genomic landscape of idh-mutant primary glioblastomas shows distinct clinical and molecular features and that CDKN2A should be supplemented with MGMTp and G-CIMP for precise prognostication (2020)
Wong, Queenie Hoi-Wing; Wong, Gabriel Chun-Hei; Chan, Aden Ka-Yin; Poon, Wai Sang; Chan, Danny Tat-Ming; Chen, Hong; Zhang, Zhen-yu; Noushmehr, Houtan ; Jones, Chris; Grabovska, Yura; Mackay, Alan; Chow, Chit; Kwan, Johnny Sheung Him; Chung, Nellie Yuk-Fei; Huang, Queenie Junqi; Poon, Manix Fung-Man; Shi, Zhi-feng; Li, Kay Ka-Wai; Ng, Ho-Keung
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: GLIOMA, NEOPLASIAS CEREBRAIS, SEQUENCIAMENTO GENÉTICO, RNA, GENÔMICA, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WONG, Queenie Hoi-Wing et al. Genomic landscape of idh-mutant primary glioblastomas shows distinct clinical and molecular features and that CDKN2A should be supplemented with MGMTp and G-CIMP for precise prognostication. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noaa215.704. Acesso em: 25 abr. 2026. , 2020
APA
Wong, Q. H. -W., Wong, G. C. -H., Chan, A. K. -Y., Poon, W. S., Chan, D. T. -M., Chen, H., et al. (2020). Genomic landscape of idh-mutant primary glioblastomas shows distinct clinical and molecular features and that CDKN2A should be supplemented with MGMTp and G-CIMP for precise prognostication. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noaa215.704
NLM
Wong QH-W, Wong GC-H, Chan AK-Y, Poon WS, Chan DT-M, Chen H, Zhang Z-yu, Noushmehr H, Jones C, Grabovska Y, Mackay A, Chow C, Kwan JSH, Chung NY-F, Huang QJ, Poon MF-M, Shi Z-feng, Li KK-W, Ng H-K. Genomic landscape of idh-mutant primary glioblastomas shows distinct clinical and molecular features and that CDKN2A should be supplemented with MGMTp and G-CIMP for precise prognostication [Internet]. Neuro-Oncology. 2020 ; 22 ii169.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noaa215.704
Vancouver
Wong QH-W, Wong GC-H, Chan AK-Y, Poon WS, Chan DT-M, Chen H, Zhang Z-yu, Noushmehr H, Jones C, Grabovska Y, Mackay A, Chow C, Kwan JSH, Chung NY-F, Huang QJ, Poon MF-M, Shi Z-feng, Li KK-W, Ng H-K. Genomic landscape of idh-mutant primary glioblastomas shows distinct clinical and molecular features and that CDKN2A should be supplemented with MGMTp and G-CIMP for precise prognostication [Internet]. Neuro-Oncology. 2020 ; 22 ii169.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noaa215.704
Trabalho de evento-resumo periodico
Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon (2020)
Tesileanu, C. Mircea S.; Van den Bent, Martin; Sabedot, Thais; Sanson, Marc; Brandes, Alba; Wick, Wolfgang; Clement, Paul; Erridge, Sarah; Vogelbaum, Michael; Nowak, Anna; Baurain, Jean; Mason, Warren; Wheeler, Helen; Weller, Michael; Heer, Iris de; Dubbink, Hendrikus; Kros, Johan M; Aldape, Kenneth; Wesseling, Pieter; Golfinopoulos, Vassilis; Gorlia, Thierry; Baumert, Brigitta; Noushmehr, Houtan ; French, Pim
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: EPIGÊNESE GENÉTICA, GLIOMA, NEOPLASIAS CEREBRAIS, METILAÇÃO DE DNA, RADIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TESILEANU, C. Mircea S. et al. Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noaa215.693. Acesso em: 25 abr. 2026. , 2020
APA
Tesileanu, C. M. S., Van den Bent, M., Sabedot, T., Sanson, M., Brandes, A., Wick, W., et al. (2020). Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noaa215.693
NLM
Tesileanu CMS, Van den Bent M, Sabedot T, Sanson M, Brandes A, Wick W, Clement P, Erridge S, Vogelbaum M, Nowak A, Baurain J, Mason W, Wheeler H, Weller M, Heer I de, Dubbink H, Kros JM, Aldape K, Wesseling P, Golfinopoulos V, Gorlia T, Baumert B, Noushmehr H, French P. Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon [Internet]. Neuro-Oncology. 2020 ; 22( suppl. 2): ii166.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noaa215.693
Vancouver
Tesileanu CMS, Van den Bent M, Sabedot T, Sanson M, Brandes A, Wick W, Clement P, Erridge S, Vogelbaum M, Nowak A, Baurain J, Mason W, Wheeler H, Weller M, Heer I de, Dubbink H, Kros JM, Aldape K, Wesseling P, Golfinopoulos V, Gorlia T, Baumert B, Noushmehr H, French P. Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon [Internet]. Neuro-Oncology. 2020 ; 22( suppl. 2): ii166.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noaa215.693
Artigo de periodico
DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management (2019)
Nassiri, Farshad; Mamatjan, Yasin; Suppiah, Suganth; Badhiwala, Jetan H.; Mansouri, Sheila; Karimi, Shirin; Saarela, Olli; Poisson, Laila; Gepfner-Tuma, Irina; Schittenhelm, Jens; Noushmehr, Houtan
Source: Neuro-Oncology. Unidade: FMRP
Subjects: MENINGIOMA, METILAÇÃO, DNA, RADIOTERAPIA, ESTUDOS DE VALIDAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASSIRI, Farshad et al. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro-Oncology, v. 21, n. 7, p. 901-910, 2019Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noz061. Acesso em: 25 abr. 2026.
APA
Nassiri, F., Mamatjan, Y., Suppiah, S., Badhiwala, J. H., Mansouri, S., Karimi, S., et al. (2019). DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro-Oncology, 21( 7), 901-910. doi:10.1093/neuonc/noz061
NLM
Nassiri F, Mamatjan Y, Suppiah S, Badhiwala JH, Mansouri S, Karimi S, Saarela O, Poisson L, Gepfner-Tuma I, Schittenhelm J, Noushmehr H. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management [Internet]. Neuro-Oncology. 2019 ; 21( 7): 901-910.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noz061
Vancouver
Nassiri F, Mamatjan Y, Suppiah S, Badhiwala JH, Mansouri S, Karimi S, Saarela O, Poisson L, Gepfner-Tuma I, Schittenhelm J, Noushmehr H. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management [Internet]. Neuro-Oncology. 2019 ; 21( 7): 901-910.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noz061
Trabalho de evento-resumo periodico
Combined epigenetic signature and gene copy number variations in IDH-mutant glioblastomas showed varied risk stratification (2019)
Ng, Hon Keung; Li, Kay Ka-Wai; Malta, Tathiane M.; Shi, Zhi-feng; Noushmehr, Houtan
Source: Neuro-Oncology. Conference titles: Annual Conference British Neuro-Oncology Society - BNOS. Unidade: FMRP
Subjects: EPIGÊNESE GENÉTICA, NEOPLASIAS CEREBRAIS, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NG, Hon Keung et al. Combined epigenetic signature and gene copy number variations in IDH-mutant glioblastomas showed varied risk stratification. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noz167.006. Acesso em: 25 abr. 2026. , 2019
APA
Ng, H. K., Li, K. K. -W., Malta, T. M., Shi, Z. -feng, & Noushmehr, H. (2019). Combined epigenetic signature and gene copy number variations in IDH-mutant glioblastomas showed varied risk stratification. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noz167.006
NLM
Ng HK, Li KK-W, Malta TM, Shi Z-feng, Noushmehr H. Combined epigenetic signature and gene copy number variations in IDH-mutant glioblastomas showed varied risk stratification [Internet]. Neuro-Oncology. 2019 ; 21 iv2.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noz167.006
Vancouver
Ng HK, Li KK-W, Malta TM, Shi Z-feng, Noushmehr H. Combined epigenetic signature and gene copy number variations in IDH-mutant glioblastomas showed varied risk stratification [Internet]. Neuro-Oncology. 2019 ; 21 iv2.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noz167.006
Trabalho de evento-resumo periodico
Modified chromatin histone marks at noncoding elements are associated with aggressive meningioma subtype (2019)
Malta, T.; Sabedot, T.; Lee, I.; Wells, M.; Castro, A.; Noushmehr, Houtan
Source: Neuro-Oncology. Conference titles: Annual Meeting European Association of Neuro-Oncology - EANO. Unidade: FMRP
Subjects: NEOPLASIAS DO SISTEMA NERVOSO, MENINGIOMA, CROMATINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTA, T. et al. Modified chromatin histone marks at noncoding elements are associated with aggressive meningioma subtype. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noz126.058. Acesso em: 25 abr. 2026. , 2019
APA
Malta, T., Sabedot, T., Lee, I., Wells, M., Castro, A., & Noushmehr, H. (2019). Modified chromatin histone marks at noncoding elements are associated with aggressive meningioma subtype. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noz126.058
NLM
Malta T, Sabedot T, Lee I, Wells M, Castro A, Noushmehr H. Modified chromatin histone marks at noncoding elements are associated with aggressive meningioma subtype [Internet]. Neuro-Oncology. 2019 ; 21 iii7.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noz126.058
Vancouver
Malta T, Sabedot T, Lee I, Wells M, Castro A, Noushmehr H. Modified chromatin histone marks at noncoding elements are associated with aggressive meningioma subtype [Internet]. Neuro-Oncology. 2019 ; 21 iii7.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noz126.058
Trabalho de evento-resumo periodico
Serum-derived DNA methylation markers distinguish functional and invasiveness subtypes in patients harboring pituitary tumors (2019)
Castro, Ana Valéria; Wells, M.; Asmaro, K.; Sabedot, T. S.; Mosella, M. S.; Malta, T. M.; Nelson, K.; Snyder, J.; Carvalho, A. de; Noushmehr, Houtan
Source: Neuro-Oncology. Conference titles: Annual Meeting European Association of Neuro-Oncology - EANO. Unidade: FMRP
Subjects: TUMOR CARCINOIDE, GLÂNDULA PITUITÁRIA, MARCADOR MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Ana Valéria et al. Serum-derived DNA methylation markers distinguish functional and invasiveness subtypes in patients harboring pituitary tumors. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noz126.080. Acesso em: 25 abr. 2026. , 2019
APA
Castro, A. V., Wells, M., Asmaro, K., Sabedot, T. S., Mosella, M. S., Malta, T. M., et al. (2019). Serum-derived DNA methylation markers distinguish functional and invasiveness subtypes in patients harboring pituitary tumors. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noz126.080
NLM
Castro AV, Wells M, Asmaro K, Sabedot TS, Mosella MS, Malta TM, Nelson K, Snyder J, Carvalho A de, Noushmehr H. Serum-derived DNA methylation markers distinguish functional and invasiveness subtypes in patients harboring pituitary tumors [Internet]. Neuro-Oncology. 2019 ; 21 iii24.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noz126.080
Vancouver
Castro AV, Wells M, Asmaro K, Sabedot TS, Mosella MS, Malta TM, Nelson K, Snyder J, Carvalho A de, Noushmehr H. Serum-derived DNA methylation markers distinguish functional and invasiveness subtypes in patients harboring pituitary tumors [Internet]. Neuro-Oncology. 2019 ; 21 iii24.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noz126.080
Trabalho de evento-resumo periodico
DNA methylation abnormalities in non-promoter regulatory regions are associated with invasive behavior in pituitary tumors (2019)
Mosella, Maritza Queiroz Salas ; Sabedot, Thais Sarraf; Malta, Tathiane Maistro; Rock, J.; Felicella, M.; Aho, T.; Noushmehr, Houtan ; Castro, A. V.
Source: Neuro-Oncology. Conference titles: Annual Meeting European Association of Neuro-Oncology - EANO. Unidade: FMRP
Subjects: GLÂNDULA PITUITÁRIA, TUMOR CARCINOIDE, METILAÇÃO DE DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOSELLA, Maritza Queiroz Salas et al. DNA methylation abnormalities in non-promoter regulatory regions are associated with invasive behavior in pituitary tumors. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noz126.236. Acesso em: 25 abr. 2026. , 2019
APA
Mosella, M. Q. S., Sabedot, T. S., Malta, T. M., Rock, J., Felicella, M., Aho, T., et al. (2019). DNA methylation abnormalities in non-promoter regulatory regions are associated with invasive behavior in pituitary tumors. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noz126.236
NLM
Mosella MQS, Sabedot TS, Malta TM, Rock J, Felicella M, Aho T, Noushmehr H, Castro AV. DNA methylation abnormalities in non-promoter regulatory regions are associated with invasive behavior in pituitary tumors [Internet]. Neuro-Oncology. 2019 ; 21 iii65.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noz126.236
Vancouver
Mosella MQS, Sabedot TS, Malta TM, Rock J, Felicella M, Aho T, Noushmehr H, Castro AV. DNA methylation abnormalities in non-promoter regulatory regions are associated with invasive behavior in pituitary tumors [Internet]. Neuro-Oncology. 2019 ; 21 iii65.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/noz126.236
Trabalho de evento-resumo periodico
Detection of glioma and prognostic subtypes by non-invasive circulating cell-free DNA methylation markers (2019)
Noushmehr, Houtan ; Sabedot, T.; Malta, T.; Nelson, K.; Snyder, J.; Wells, M.; Carvalho, A. de; Mukherjee, A.; Chitale, D.; Mosella, M.
Source: Neuro-Oncology. Conference titles: Annual Meeting European Association of Neuro-Oncology - EANO. Unidade: FMRP
Subjects: GLIOMA, MARCADOR MOLECULAR, CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOUSHMEHR, Houtan et al. Detection of glioma and prognostic subtypes by non-invasive circulating cell-free DNA methylation markers. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1101/601245. Acesso em: 25 abr. 2026. , 2019
APA
Noushmehr, H., Sabedot, T., Malta, T., Nelson, K., Snyder, J., Wells, M., et al. (2019). Detection of glioma and prognostic subtypes by non-invasive circulating cell-free DNA methylation markers. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1101/601245
NLM
Noushmehr H, Sabedot T, Malta T, Nelson K, Snyder J, Wells M, Carvalho A de, Mukherjee A, Chitale D, Mosella M. Detection of glioma and prognostic subtypes by non-invasive circulating cell-free DNA methylation markers [Internet]. Neuro-Oncology. 2019 ; 21 iii6.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1101/601245
Vancouver
Noushmehr H, Sabedot T, Malta T, Nelson K, Snyder J, Wells M, Carvalho A de, Mukherjee A, Chitale D, Mosella M. Detection of glioma and prognostic subtypes by non-invasive circulating cell-free DNA methylation markers [Internet]. Neuro-Oncology. 2019 ; 21 iii6.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1101/601245
Artigo de periodico
Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications (2018)
Malta, Tathiane M.; Souza, Camila F. de; Sabedot, Thais S.; Silva, Tiago C.; Mosella, Maritza S.; Kalkanis, Steven N.; Snyder, James; Castro, Ana Valeria B.; Noushmehr, Houtan
Source: Neuro-Oncology. Unidade: FMRP
Subjects: GLIOMA, METILAÇÃO DE DNA, MUTAÇÃO GENÉTICA, GENOMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTA, Tathiane M. et al. Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications. Neuro-Oncology, v. 20, n. 5, p. 608-620, 2018Tradução . . Disponível em: https://doi.org/10.1093/neuonc/nox183. Acesso em: 25 abr. 2026.
APA
Malta, T. M., Souza, C. F. de, Sabedot, T. S., Silva, T. C., Mosella, M. S., Kalkanis, S. N., et al. (2018). Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications. Neuro-Oncology, 20( 5), 608-620. doi:10.1093/neuonc/nox183
NLM
Malta TM, Souza CF de, Sabedot TS, Silva TC, Mosella MS, Kalkanis SN, Snyder J, Castro AVB, Noushmehr H. Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications [Internet]. Neuro-Oncology. 2018 ; 20( 5): 608-620.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/nox183
Vancouver
Malta TM, Souza CF de, Sabedot TS, Silva TC, Mosella MS, Kalkanis SN, Snyder J, Castro AVB, Noushmehr H. Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications [Internet]. Neuro-Oncology. 2018 ; 20( 5): 608-620.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1093/neuonc/nox183

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Conference titles

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration